Cosmo Pharmaceuticals
Ireland - Dublin
PharmaceuticalFocus: Specialty pharmaceuticals
Cosmo Pharmaceuticals is a life sciences company focused on Specialty pharmaceuticals.
Neurology
Funding Stage
PUBLIC
Open Jobs
4
Products & Portfolio (1)
Pipeline & Clinical Trials
Endoscopic Mucosal Resection of large colon polyps
AdenomasClinical Trials (1)
NCT02654418Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm
N/Aoral tablet dye for detection of polyps during colonoscopy
Polyp and Adenoma Detection During ColonoscopyClinical Trials (1)
NCT01520337Polyp Detection Rate After Single Oral Dose of Methylene Blue MMX Modified Release Tablets Administered to Subjects Undergoing Outpatients Colonoscopy
N/APowered Exoskeleton Gait Training
Cerebral PalsyClinical Trials (1)
NCT05759182The Effects of Exoskeletal Robot-Assisted Gait Training on Children With Cerebral Palsy: A Pilot Study
N/ACold snare EMR
Colonic PolypClinical Trials (1)
NCT03865537Cold Snare Endoscopic Mucosal Resection Trial
N/APediatric Lower Limb Exoskeleton
Cerebral Palsy (CP)Clinical Trials (1)
NCT07146932Evaluating the Bambini Teens Exoskeleton for Pediatric Cerebral Palsy
N/Amonitor for depth of hypnosis
Consciousness, Level DepressedClinical Trials (1)
NCT01800578Awareness During Blended Anaesthesia
N/Asoftware GI Genius™ XR on headset
Colonoscopy (Procedure)Clinical Trials (1)
NCT07220174Use of GI Genius™ XR Software in Virtual Reality Headset During Routine Colonoscopy
N/AExoAtlet II
Spinal Cord InjuriesClinical Trials (1)
NCT04532723Exoskeleton-Assisted Walking ExoAtlet II
N/AGI Genius CADe system
Artificial IntelligenceClinical Trials (1)
NCT04589078Polyp REcognition Assisted by a Device Interactive Characterization Tool - The PREDICT Study
N/AColonoscopy
Colon CancerClinical Trials (1)
NCT06216405Performance of Artificial Intelligence in Colonoscopy for Right Colon Polyp Detection
N/ACB-17-08 CADe
Colorectal CancerClinical Trials (1)
NCT03954548CB-17-08 Augmented Endoscopy System for Mucosal Lesion Detection During Colonoscopy for Colon Rectal Cancer.
N/AGait training using ExoAtlet exoskeleton
Spinal Cord InjuriesClinical Trials (1)
NCT04215081ExoAtlet II For SCI Patients
N/ATransgenic Lymphocyte Immunization Vaccine
Prostatic NeoplasmsClinical Trials (1)
NCT00061035Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate Adenocarcinoma
Phase 1Rifamycin SV-MMX® 600
HealthyClinical Trials (1)
NCT02969252Pharmacokinetics and Safety Study of Rifamycin SV-MMX® 600 mg Tablets After Single and Multiple t.i.d. Doses in Healthy Male and Female Volunteers
Phase 1CB-03-10
Advanced Refractory Solid TumorsClinical Trials (1)
NCT03863145Study to Evaluate Maximum Tolerated Dose of Oral CB-03-10 With Dose Expansion Phase, in Advanced Solid Tumors
Phase 1Rifamycin SV 600mg t.i.d.
Diarrhea-predominant Irritable Bowel SyndromeClinical Trials (1)
NCT03099785Rifamycin SV-MMX® 600 mg Tablets Administered Three or Two Times Daily to Patients With IBS-D
Phase 2Sigmoidoscopy
Ulcerative ColitisClinical Trials (1)
NCT00867438Efficacy and Tolerability of a New Oral Extended-Release Formulation Containing Parnaparin Sodium, Administered Add-on Therapy
Phase 2Methylene Blue MMX 25 mg modified release tablets
Colon Staining in Preparation for ColonoscopyClinical Trials (1)
NCT03287219Colon Staining Efficacy of Single Oral Doses of Methylene Blue MMX
Phase 2standard white light colonoscopy-equivalent to placebo
Colorectal CancerClinical Trials (1)
NCT02295774Effect of Oral Administration of Methylene Blue MMX Tablets on Double Stranded DNA
Phase 2oral delivery mucosal stain
Ulcerative ColitisClinical Trials (1)
NCT01520324Neoplasia Detection With Methylene Blue MMX Tablets in Patients With UC Undergoing Colonoscopy
Phase 2CB-10-01
Stage IIIB Skin MelanomaClinical Trials (1)
NCT00925314A Study of Transgenic Lymphocyte Immunization (TLI) Against Telomerase in Subjects With Stage III Melanoma
Phase 2400 mg Rifamycin SV dosage
Infectious DiarrhoeaClinical Trials (1)
NCT03447821Efficacy and Safety of CB-01-11 200mg Tablets in Infectious Diarrhoea
Phase 2Budesonide
Colitis, UlcerativeClinical Trials (1)
NCT01100112(CB-01-02/06) Oral Budesonide-Multi-Matrix System (MMX) 9mg Extended Release Tablets
Phase 3Methylene Blue MMX®
Colorectal CancerClinical Trials (1)
NCT01694966The Safety and Efficacy of Methylene Blue MMX® Modified Release Tablets Administered to Subjects Undergoing Screening or Surveillance Colonoscopy
Phase 3Blood sampling, endoscopy
Ulcerative ColitisClinical Trials (1)
NCT00679380(CB-01-02/02) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative Colitis
Phase 3Placebo
Traveler's DiarrheaClinical Trials (1)
NCT01142089Study to Evaluate Safety and Efficacy of Rifamycin SV Multi-Matrix System (MMX) for the Treatment of Traveler's Diarrhea (TD)
Phase 3Open Jobs (4)
Interview Prep Quick Facts
Portfolio: 1 approved product, 26 clinical trials
Open Roles: 4 active jobs
Portfolio Health
Post-LOE1 (100%)
1 total products